Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
Stock data | 2024 | Change |
---|---|---|
Price | $0.481803661707829 | N/A |
Market Cap | $145.22M | N/A |
Shares Outstanding | 301.41M | N/A |
Employees | 12.00 | N/A |